Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Site Map
2019
December
11
Celmatix takes ex-partner 23andMe to court over soured 'femtech' deal
CAP deems surprise billing deal 'unacceptable'
Inflammatory marker sCD14 lurks in dementia
Page 1 of 1